100 related articles for article (PubMed ID: 2770306)
1. Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck carcinomas.
Parnes SM; Bennett JA; Deconti RC; Sagerman P
J Surg Oncol; 1989 Sep; 42(1):21-7. PubMed ID: 2770306
[TBL] [Abstract][Full Text] [Related]
2. Growth and chemosensitivity of human head and neck cancers implanted under the kidney capsule of cyclosporine-immunosuppressed mice.
Bennett JA; Parnes SM; DeConti RC
Ann Otol Rhinol Laryngol; 1989 Jun; 98(6):455-60. PubMed ID: 2729831
[TBL] [Abstract][Full Text] [Related]
3. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
4. Subrenal capsule assay for squamous cell carcinoma of the head and neck.
Stiernberg CM; Rotzler WH; Valyi-Nagy K; Hokanson JA; Hale PE
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):177-81. PubMed ID: 3108755
[TBL] [Abstract][Full Text] [Related]
5. A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay.
Munakata H; Kayada Y; Kawahara M; Sakamoto T; Yoshiga K; Takada K
Int J Oral Maxillofac Surg; 1995 Jun; 24(3):216-20. PubMed ID: 7594755
[TBL] [Abstract][Full Text] [Related]
6. Drug response of head and neck tumors in native-state histoculture.
Robbins KT; Varki NM; Storniolo AM; Hoffman H; Hoffman RM
Arch Otolaryngol Head Neck Surg; 1991 Jan; 117(1):83-6. PubMed ID: 1986767
[TBL] [Abstract][Full Text] [Related]
7. Murine subrenal capsule assay: prediction of chemoresponsiveness in head and neck cancer.
Panje WR; McCormick KJ
Laryngoscope; 1989 Jan; 99(1):41-9. PubMed ID: 2642583
[TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay].
Suzuki K; Fujii M; Ishii Y; Mochizuki F; Suzuki K; Yamagata M; Suzuki H; Moriya Y; Abiko Y; Sakabe T
Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253
[TBL] [Abstract][Full Text] [Related]
9. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
10. Single agent chemotherapy for head and neck cancers. The murine subrenal capsule assay.
McCormick KJ; Panje WR; Seltzer S; Merrick RH
Arch Otolaryngol; 1983 Nov; 109(11):715-8. PubMed ID: 6314954
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic response of squamous cell carcinoma xenografts (subcutaneous and subrenal capsule assay).
Rajnay J; Kopper L; Lapis K
Oncology; 1987; 44(5):307-11. PubMed ID: 3670798
[TBL] [Abstract][Full Text] [Related]
12. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas.
Nakashima T; Maehara Y; Kohnoe S; Hayashi I; Katsuta Y
Head Neck; 1990; 12(5):406-10. PubMed ID: 2211101
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region.
Elprana D; Kuijpers W; Wessels JM; Wagener DJ; van den Broek P
Anticancer Res; 1992; 12(6B):2229-39. PubMed ID: 1284201
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of individual sensitivity to chemotherapy of human pulmonary tumors transplanted to subrenal capsule of CBA mice].
Skotinkova OI; Sergeeva NS; Moroz IA; Sviridova IK; Pelevina II
Eksp Onkol; 1990; 12(4):71-3. PubMed ID: 2379492
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitivity of squamous cell carcinoma grown in implantable chambers.
Castillo MH; Rullan P; Perkins E; Sands A; Banyas JB; Homs M; Doerr R
Am J Otolaryngol; 1989; 10(2):71-5. PubMed ID: 2929884
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations.
Dollner R; Granzow C; Neudert M; Dietz A
Anticancer Res; 2006; 26(2B):1651-5. PubMed ID: 16619587
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric flow cytometry of human squamous cell carcinoma lines from the head and neck.
Wustrow TP; Raffael A; Valet G
Otolaryngol Head Neck Surg; 1988 Jun; 98(6):552-7. PubMed ID: 3138611
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
Boerrigter GH; Heinerman EC; Braakhuis BJ; Snow GB
Br J Cancer; 1986 Jul; 54(1):53-9. PubMed ID: 3730256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
